Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:age |
gptkb:Person
infants |
gptkbp:associated_with |
pediatric cancer
|
gptkbp:clinical_trial |
ongoing
hormonal changes neurological symptoms rapid growth |
gptkbp:end_of_life |
improving
|
gptkbp:events |
rehabilitation services
regular monitoring psychosocial support |
gptkbp:genetic_diversity |
gptkb:physicist
MYCN amplification 1p deletion |
https://www.w3.org/2000/01/rdf-schema#label |
embryonal tumor
|
gptkbp:is_a_tool_for |
gptkb:MRI
CT scan PET scan |
gptkbp:is_involved_in |
family support networks
pediatric cancer organizations |
gptkbp:is_standardized_by |
gptkb:healthcare_organization
gptkb:neuroblastoma medulloblastoma |
gptkbp:located_in |
central nervous system
|
gptkbp:number_of_stages |
localized
metastatic |
gptkbp:occurs_in |
rare
|
gptkbp:research_focus |
gptkb:vaccine
biomarkers targeted therapy |
gptkbp:risk_factor |
genetic predisposition
environmental exposure |
gptkbp:social_responsibility |
varies by region
imaging studies varies by type biopsy higher incidence in males associated syndromes |
gptkbp:symptoms |
weight loss
fever pain neurological deficits abdominal mass |
gptkbp:treatment |
gptkb:hospital
palliative care radiation therapy chemotherapy recurrence long-term effects clinical management remission multimodal therapy |
gptkbp:type |
gptkb:healthcare_organization
|
gptkbp:bfsParent |
gptkb:nephroblastoma
gptkb:Wilms'_tumor |
gptkbp:bfsLayer |
6
|